electroCore, Inc. (ECOR) stock
Close on Nov 11, 2026Market cap $69.51MP/E –Yield –
electroCore, Inc. grew revenue 27.3% to $37.97M over the twelve months to Sep 30, 2026. Free cash flow was -$10.90M. At the latest close the market valued the company at $69.51M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $69.51M
- P/E ratio
- –
- Price to sales
- 1.83
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -15.68%
Fundamentals
- Revenue
- $37.97M
- Net income
- -$12.70M
- EPS, diluted
- -$1.65
- Free cash flow
- -$10.90M
- Book value per share
- -$0.25
- Diluted shares
- 10M
Trading
- Next earnings
- Mar 18, 2027 (estimated, during market hours)
- Previous close
- $7.72
- Open
- $7.67
- Day's range
- $7.62 – $8.32
- Volume
- 63,390
- Average volume (20 days)
- 111,082
- Beta (5 years)
- 1.15
- 52-week range
- $4.41 – $12.70
- RSI (14 days)
- 45.6
- Volatility (1 year)
- 89.3%
- Relative volume
- 0.68×
- WACC
- 10.0%
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ECOR | S&P 500 | Difference | ECOR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -20.2% | -2.4% | −17.8 pts | ||
| 3 months | -15.5% | -1.2% | −14.3 pts | ||
| Year to date | +71.9% | +12.3% | +59.6 pts | ||
| 1 year | +22.4% | +12.4% | +9.9 pts | ||
| 3 years | +34.3% | +78.8% | −44.5 pts | +10.3% | +21.4% |
| 5 years | -44.9% | +75.2% | −120.1 pts | -11.2% | +11.9% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases electroCore filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Results
About electroCore
Electromedical & Electrotherapeutic Apparatus
electroCore, Inc. is a bioelectronic technology company that develops and markets non-invasive bioelectronic devices and medical solutions. The company operates through two primary product categories: personal-use prescription medical devices for managing conditions such as primary headache and fibromyalgia, and personal-use consumer products designed to promote general wellness and human performance. Key prescription offerings include gammaCore, a non-invasive vagus nerve stimulation device for primary headache conditions, and the wearable Quell Fibromyalgia neuromodulation device. Consumer-oriented offerings include Truvaga for wellness and TAC-STIM for military and professional operational performance. The company serves patients through healthcare providers and commercial channels, with major institutional customers including the U.S. Department of Veterans Affairs, the U.S. Department of Defense, and the U.K. National Health Service.
Company profile, executives and historyelectroCore stock: common questions
What is electroCore's stock price?
ECOR closed at $7.71 on Nov 11, 2026, down 0.13% on the day. Over the past 52 weeks it traded between $4.41 and $12.70.
What is electroCore's market cap?
electroCore was worth $69.51M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ECOR's P/E ratio?
electroCore lost money over fiscal 2025 (diluted EPS -$1.65), so it has no meaningful P/E ratio.
How much revenue does electroCore make?
electroCore reported revenue of $37.97M for the twelve months to Sep 30, 2026, up 27.3% from a year earlier.
Does electroCore pay a dividend?
No. electroCore has not paid a cash dividend over the last twelve months.
When does electroCore report earnings next?
electroCore is expected to report Q4 FY2026 results on Mar 18, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has ECOR stock performed over the past year?
Including dividends, ECOR returned +22.4% over the past year, against +12.4% for the S&P 500.
How many ECOR shares are sold short?
0M shares were sold short at the latest FINRA report, 4.78% of the float, or 5.2 days of average trading volume.
Who are electroCore's competitors?
Companies most similar to electroCore by business, industry and size include ELMD, FOCL, IRIX, VASO, STXS.
See a number that looks wrong?